IGC Financials
Igc Pharma Inc - Financial statements & key metrics
Stock Price
$0.31
Market Cap
$30.64M
EPS
$-0.06
Income Statement Highlights
Most Recent Quarter: 2025-03-31
Revenue
$1.27M
Gross Profit
-
Operating Income
-
Net Income
$-7.12M
EPS (Diluted)
$-0.09
Balance Sheet Highlights
Total Assets
$8.75M
Total Liabilities
$2.42M
Shareholders Equity
-
Cash & Equivalents
$405,000
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-4.79M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
46.2%
Operating Margin
-15.2%
ROE
-0.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IGC revenue?
IGC's most recent quarterly revenue was $1.27M. Annual revenue can be calculated by summing the four most recent quarters.
Is IGC profitable?
IGC reported a loss of $7.12M in the most recent quarter.
What is IGC market cap?
IGC has a market capitalization of $30.64M, making it a small-cap stock.
Does IGC have debt?
View IGC's balance sheet for debt information.
What is IGC cash flow?
Cash flow data is available in the full financial statements.